BMTCN EXAM AND PRACTICE EXAM NEWEST 2026 TEST
A/TEST B | BLOOD & MARROW TRANSPLANT CERTIFIED
NURSE (BMTCN) EXAM PREP WITH COMPLETE 550+
EXAM QUESTIONS AND CORRECT DETAILED ANSWERS
(VERIFIED ANSWERS) ALREADY GRADED A+
When a patient senses a leaking in IV site during a chemotherapy
infusion, what does the nurse do first?
A. Place warning signs across the area to alert others to the spill
B. Restart the chemotherapy with a new order
C. Put on the right safety gear
D. Environmental programs should be contacted ......ANSWER......A.
Place a warning signs across the area to alert others to the spill
Explanation: People who treat or come into contact with chemotherapy
drugs are known to be at risk. This suggests that the medicines are
powerful enough to harm or destroy cancer cells, which is good news
for patients. However, this means that drugs could pose a risk to those
who are exposed to them. This is why chemo drug handlers must
adhere to such safety guidelines and recommendations. If IV chemo is
spilled, powder or dust from a pill or tablet, or liquid from oral or other
types of chemo is present, it may be dangerous to others.
Which of the following is the leading cause of death after a cord blood
transplant?
pg. 1
,A. Infection
B. Bleeding
C. Malnutrition
D. Renal Failure ......ANSWER......A. Infection
Explanation: Like bone marrow and peripheral blood, umbilical cord
blood is risk source of stem cells for transplantation. It does, however,
come with a few risks. "Infection" is one of the most serious risks that
can lead to death. Infection is thought to be responsible for 35-50% of
non-relapse mortality in UCBT patients, compared to 8-22% in
allogeneic HCT patients. Following UCBT, viral infection, particularly
cytomegalovirus (CMV) and human herpesvirus 6 (HHV-6), have been
linked to an increase in morbidity and death.
Which of the following drugs will most likely lead to heart failure as
being used in the conditioning regimen?
A. Busulfan
B. Cytarabine
C. Fludarabine
D. Cyclophosphamide ......ANSWER......D. Cyclophosphamide
Explanation: Cardiac toxicity is the result of harmful chemicals causing
damage to the heart. Toxins (drugs) may be administered to you as part
of your treatment to destroy cancer cells. Normal cells in and around
your heart can also be killed as a side effect. Patients taking a
cumulative dose of more than 150mg/kg cyclophosphamide have a 7-
33% chance of developing acute heart failure. Depending on the dosing
pg. 2
,regimen and patient population, fatal cyclophosphamide
cardiomyopathy can range from 2 to 17%.
Daisy has leukemia. She will require HSCT treatment. In this situation,
which of the following is the most important thing for the nurse to
consider while teaching her caregiver?
A. Request that the teaching be done by a nurse who is not caring for
the patient
B. Discuss the probability of transferring the details to someone other
than the caregiver
C. Concentrate on details about the present stage of treatment
D. Keep track of the caregiver's emotional reaction ......ANSWER......C.
Concentrate on details about the present stage of treatment
Explanation: A successful caregiver must have the ability to develop
adequate coping strategies, solve problems, and prioritize. To be able to
offer adequate treatment for an HSCT recipient, the caregiver must
preserve his or her own quality of life -- including mental, physical, and
emotional health -- during the transplanting phase. Since the conditions
of patients and their caregivers change with each phase of treatment,
it's critical to customize teaching to the particular phase of treatment.
Under utilization for certain diseases occurs due to transplant-related
toxicity. For which of the following disease is transplant-related toxicity
a barrier?
A. Neuroblastoma
B. Arrhythmia
pg. 3
, C. Acute Myeloid Leukemia
D. Sickle Cell Disease ......ANSWER......D. Sickle Cell Disease
Explanation: While the clinical course of sickle cell disease (SCD) varies,
many patients experience end-organ complications that are associated
with severe morbidity and mortality. While myeloablative allogeneic
HSCT (allo-HSCT) is curative, it has traditionally been reserved for
children under the age of 16. Sickle cell disease (SCD) is triggered by a
single nucleotide mutation in the -globin protein, which replaces
glutamate with valine in the 6th spot. The hemoglobin protein is more
likely to polymerize when deoxygenated as a result of this transition,
resulting in sickle-shaped red cells.
Identify which among the following electrolyte abnormalities, is not
characterized as an acute tumor lysis syndrome?
A. Hypocalcemia
B. Hyperkalemia
C. Hyperuricermia
D. Hypophosphatemia ......ANSWER......D. Hypophosphatemia
Explanation: TLS is a situation in which a significant number of cancer
cells die in a short amount of time, releasing thier contents into the
bloodstream. Hypophosphatemia is defined as a phosphate level in the
blood of an adult of less than 2.5 (mg/dL). The typical amount of serum
phosphate in children is much greater, with children have a level of
7mg/dL. Hypophosphatemia is a fairly common laboratory condition
that is frequently discovered by chance.
pg. 4
A/TEST B | BLOOD & MARROW TRANSPLANT CERTIFIED
NURSE (BMTCN) EXAM PREP WITH COMPLETE 550+
EXAM QUESTIONS AND CORRECT DETAILED ANSWERS
(VERIFIED ANSWERS) ALREADY GRADED A+
When a patient senses a leaking in IV site during a chemotherapy
infusion, what does the nurse do first?
A. Place warning signs across the area to alert others to the spill
B. Restart the chemotherapy with a new order
C. Put on the right safety gear
D. Environmental programs should be contacted ......ANSWER......A.
Place a warning signs across the area to alert others to the spill
Explanation: People who treat or come into contact with chemotherapy
drugs are known to be at risk. This suggests that the medicines are
powerful enough to harm or destroy cancer cells, which is good news
for patients. However, this means that drugs could pose a risk to those
who are exposed to them. This is why chemo drug handlers must
adhere to such safety guidelines and recommendations. If IV chemo is
spilled, powder or dust from a pill or tablet, or liquid from oral or other
types of chemo is present, it may be dangerous to others.
Which of the following is the leading cause of death after a cord blood
transplant?
pg. 1
,A. Infection
B. Bleeding
C. Malnutrition
D. Renal Failure ......ANSWER......A. Infection
Explanation: Like bone marrow and peripheral blood, umbilical cord
blood is risk source of stem cells for transplantation. It does, however,
come with a few risks. "Infection" is one of the most serious risks that
can lead to death. Infection is thought to be responsible for 35-50% of
non-relapse mortality in UCBT patients, compared to 8-22% in
allogeneic HCT patients. Following UCBT, viral infection, particularly
cytomegalovirus (CMV) and human herpesvirus 6 (HHV-6), have been
linked to an increase in morbidity and death.
Which of the following drugs will most likely lead to heart failure as
being used in the conditioning regimen?
A. Busulfan
B. Cytarabine
C. Fludarabine
D. Cyclophosphamide ......ANSWER......D. Cyclophosphamide
Explanation: Cardiac toxicity is the result of harmful chemicals causing
damage to the heart. Toxins (drugs) may be administered to you as part
of your treatment to destroy cancer cells. Normal cells in and around
your heart can also be killed as a side effect. Patients taking a
cumulative dose of more than 150mg/kg cyclophosphamide have a 7-
33% chance of developing acute heart failure. Depending on the dosing
pg. 2
,regimen and patient population, fatal cyclophosphamide
cardiomyopathy can range from 2 to 17%.
Daisy has leukemia. She will require HSCT treatment. In this situation,
which of the following is the most important thing for the nurse to
consider while teaching her caregiver?
A. Request that the teaching be done by a nurse who is not caring for
the patient
B. Discuss the probability of transferring the details to someone other
than the caregiver
C. Concentrate on details about the present stage of treatment
D. Keep track of the caregiver's emotional reaction ......ANSWER......C.
Concentrate on details about the present stage of treatment
Explanation: A successful caregiver must have the ability to develop
adequate coping strategies, solve problems, and prioritize. To be able to
offer adequate treatment for an HSCT recipient, the caregiver must
preserve his or her own quality of life -- including mental, physical, and
emotional health -- during the transplanting phase. Since the conditions
of patients and their caregivers change with each phase of treatment,
it's critical to customize teaching to the particular phase of treatment.
Under utilization for certain diseases occurs due to transplant-related
toxicity. For which of the following disease is transplant-related toxicity
a barrier?
A. Neuroblastoma
B. Arrhythmia
pg. 3
, C. Acute Myeloid Leukemia
D. Sickle Cell Disease ......ANSWER......D. Sickle Cell Disease
Explanation: While the clinical course of sickle cell disease (SCD) varies,
many patients experience end-organ complications that are associated
with severe morbidity and mortality. While myeloablative allogeneic
HSCT (allo-HSCT) is curative, it has traditionally been reserved for
children under the age of 16. Sickle cell disease (SCD) is triggered by a
single nucleotide mutation in the -globin protein, which replaces
glutamate with valine in the 6th spot. The hemoglobin protein is more
likely to polymerize when deoxygenated as a result of this transition,
resulting in sickle-shaped red cells.
Identify which among the following electrolyte abnormalities, is not
characterized as an acute tumor lysis syndrome?
A. Hypocalcemia
B. Hyperkalemia
C. Hyperuricermia
D. Hypophosphatemia ......ANSWER......D. Hypophosphatemia
Explanation: TLS is a situation in which a significant number of cancer
cells die in a short amount of time, releasing thier contents into the
bloodstream. Hypophosphatemia is defined as a phosphate level in the
blood of an adult of less than 2.5 (mg/dL). The typical amount of serum
phosphate in children is much greater, with children have a level of
7mg/dL. Hypophosphatemia is a fairly common laboratory condition
that is frequently discovered by chance.
pg. 4
